The miR-3648/FRAT1-FRAT2/c-Myc negative feedback loop modulates the metastasis and invasion of gastric cancer cells
Weimei Tang,Miaomiao Pei,Jiaying Li,Nanzhu Xu,Wushuang Xiao,Zhen Yu,Jieming Zhang,Linjie Hong,Zheng Guo,Jianjiao Lin,Weiyu Dai,Yizhi Xiao,Xiaosheng Wu,Guangnan Liu,Fachao Zhi,Guoxin Li,Jing Xiong,Ye Chen,Hui Zhang,Li Xiang,Aimin Li,Side Liu,Jide Wang
DOI: https://doi.org/10.1038/s41388-022-02451-2
IF: 8.756
2022-09-25
Oncogene
Abstract:Although the abnormal expression of miRNAs in cancer cells is a widely accepted phenomenon, the molecular mechanisms underlying miR-3648 progression and metastasis in gastric cancer (GC) remain unclear. miR-3648 expression is downregulated and its ectopic expression in GC cells significantly suppressed cell proliferation and metastasis. Mechanistic analyses indicated that miR-3648 directly targets FRAT1 or FRAT2 and inhibits FRAT1- or FRAT2-mediated invasion and motility in vitro and in vivo. Moreover, FRAT1 physically interacted with FRAT2. Furthermore, FRAT1 overexpression promoted GC cell invasion, whereas siRNA-mediated repression of FRAT2 in FRAT1-overexpressing GC cells reversed its invasive potential. Besides, miR-3648 inactivated the Wnt/β-catenin signalling pathway by downregulating FRAT1 and FRAT2 in GC. Interestingly, c-Myc, a downstream effector of Wnt/β-catenin signalling, was also downregulated by miR-3648 overexpression. In turn, c-Myc negatively regulated miR-3648 expression by binding to the miR-3648 promoter. In addition, miR-3648 expression levels were negatively correlated with c-Myc, FRAT1, and FRAT2 expression in fresh gastric samples. Our studies suggest that miR-3648 acts as a tumour-suppressive miRNA and that the miR-3648/FRAT1-FRAT2/c-Myc negative feedback loop could be a critical regulator of GC progression.
oncology,genetics & heredity,biochemistry & molecular biology,cell biology